Treatment recalcitrant cases of tinea corporis/cruris caused by T. mentagrophytes – interdigitale complex with mutations in ERG11 ERG 3, ERG4, MDR1 MFS genes & SQLE and their potential implications
International Journal of Dermatology · 2023-05 · 62 (5) · 637-648
DOI: 10.1111/ijd.16622 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Dermatology, online erschienen am 17.03.2023. Verfasst von Anamika Bhattacharyya und 9 weiteren Autor:innen. Beteiligte Einrichtung: Vyome Therapeutics Limited, New Delhi, India. Hauptthemen laut MEDLINE: Antifungal Agents, Tinea. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 52 Literaturangaben.
Abstract (Originalsprache)
Background
Recalcitrant dermatophyte infections are being reported from various parts of the world due to varied causes including strain variation, steroid misuse, SQLE mutations, and variable quality of itraconazole pellet formulations. The oral drug preferred in endemic areas is itraconazole, to which MIC levels remain low, and clinical failures to itraconazole reported defy a sound scientific explanation.
Objectives
The objective of the study was to conduct a proteomic and genomic analysis on isolates from therapeutically recalcitrant case with isolation of gene mutations and enzymatic abnormalities to explain azole failures.
Methods
Trichophyton mentagrophyte interdigitale complex strains were isolated from seven clinically non‐responding tinea corporis/cruris patients, who had failed a sequential course of 6 weeks of terbinafine 250 mg QD and itraconazole 100 mg BID. After AFST 1 strain, KA01 with high MIC to most drugs was characterized using whole genome sequencing, comparative proteomic profiling, and total sterol quantification.
Results
Sterol quantification showed that the standard strain of Trichophyton mentagrophytes (MTCC‐7687) had half the ergosterol content than the resistant KA01 strain. Genomic analysis revealed mutations in SQLE , ERG4 , ERG11 , MDR1 , MFS genes, and a novel ERG3 mutation. Proteomic analysis established the aberrant expression of acetyl Co‐A transferase in the resistant strain and upregulation of thioredoxin reductase and peroxiredoxin.
Conclusion
Our findings demonstrate possible reasons for multidrug resistance in the prevalent strain with mutations in genes that predict terbinafine (SQLE) and azole actions ( ERG4 , ERG11 , ERG3 ) apart from efflux pumps ( MDR1 , MFS ) that can explain multidrug clinical failures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Vyome Therapeutics Limited, New Delhi, India.
- Department of Dermatology, Venereology and Leprosy, Dr. Ram Manohar Lohia Hospital, Atal Bihari Vajpayee Institute of Medical Sciences, New Delhi, India.
- Saraswathi Institute of Medical Sciences, Anwarpur, Uttar Pradesh, India.
ORCID-Profile: Ananta Khurana, Kabir Sardana
Zitieren
APA
Bhattacharyya, A., Sadhasivam, S., Sinha, M., Gupta, S., Saini, S., Singh, H., Khurana, A., Sachdeva, S., Sardana, K., & Ghosh, S. (2023). Treatment recalcitrant cases of tinea corporis/cruris caused by T. mentagrophytes – interdigitale complex with mutations in ERG11 ERG 3, ERG4, MDR1 MFS genes & SQLE and their potential implications. International Journal of Dermatology, 62(5), 637-648. https://doi.org/10.1111/ijd.16622
Vancouver
Bhattacharyya A, Sadhasivam S, Sinha M, Gupta S, Saini S, Singh H, et al. Treatment recalcitrant cases of tinea corporis/cruris caused by T. mentagrophytes – interdigitale complex with mutations in ERG11 ERG 3, ERG4, MDR1 MFS genes & SQLE and their potential implications. International Journal of Dermatology. 2023;62(5):637-648. doi:10.1111/ijd.16622
BibTeX
@article{Bhattacharyya2023,
author = {Bhattacharyya, Anamika and Sadhasivam, Suresh and Sinha, Mau and Gupta, Swati and Saini, Swamini and Singh, Himanshi and Khurana, Ananta and Sachdeva, Soumya and Sardana, Kabir and Ghosh, Shamik},
title = {Treatment recalcitrant cases of tinea corporis/cruris caused by T. mentagrophytes – interdigitale complex with mutations in ERG11 ERG 3, ERG4, MDR1 MFS genes & SQLE and their potential implications},
journal = {International Journal of Dermatology},
year = {2023},
volume = {62},
number = {5},
pages = {637--648},
doi = {10.1111/ijd.16622}
}
EUVIMED